ARK Genomic Revolution UCITS ETF Class A USD Accumulation (ARKG:LSE) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the ARK Genomic Revolution UCITS ETF Class A USD Accumulation stock forecast from 0 analysts, the average analyst target price for ARK Genomic Revolution UCITS ETF Class A USD Accumulation is not available over the next 12 months. ARK Genomic Revolution UCITS ETF Class A USD Accumulation’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of ARK Genomic Revolution UCITS ETF Class A USD Accumulation is Very Bearish, which is based on 0 positive signals and 1 negative signals. At the last closing, ARK Genomic Revolution UCITS ETF Class A USD Accumulation’s stock price was GBX 4.42. ARK Genomic Revolution UCITS ETF Class A USD Accumulation’s stock price has changed by -3.21% over the past week, +2.08% over the past month and 0% over the last year.
No recent analyst target price found for ARK Genomic Revolution UCITS ETF Class A USD Accumulation
No recent average analyst rating found for ARK Genomic Revolution UCITS ETF Class A USD Accumulation
Company Overview ARK Genomic Revolution UCITS ETF Class A USD Accumulation
Frequently Asked Questions About ARK Genomic Revolution UCITS ETF Class A USD Accumulation (ARKG:LSE) Stock
Stock Target Advisor's fundamental analysis for ARK Genomic Revolution UCITS ETF Class A USD Accumulation's stock is Very Bearish.
Unfortunately we do not have enough data on ARKG:LSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ARKG:LSE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ARKG:LSE's stock to indicate if its overvalued.
The last closing price of ARKG:LSE's stock was GBX 4.42.
The most recent market capitalization for ARKG:LSE is GBX 4.85M.
Unfortunately we do not have enough analyst data on ARKG:LSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains ARK Genomic Revolution UCITS ETF Class A USD Accumulation's stock.
Sorry, we do not have any data on the number of employees for ARK Genomic Revolution UCITS ETF Class A USD Accumulation.
Sorry we do not have any infomation available on ARK Genomic Revolution UCITS ETF Class A USD Accumulation's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Frequently Asked Questions About ARK Genomic Revolution UCITS ETF Class A USD Accumulation (ARKG:LSE) Stock
Stock Target Advisor's fundamental analysis for ARK Genomic Revolution UCITS ETF Class A USD Accumulation's stock is Very Bearish.
Unfortunately we do not have enough data on ARKG:LSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ARKG:LSE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ARKG:LSE's stock to indicate if its overvalued.
The last closing price of ARKG:LSE's stock was GBX 4.42.
The most recent market capitalization for ARKG:LSE is GBX 4.85M.
Unfortunately we do not have enough analyst data on ARKG:LSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains ARK Genomic Revolution UCITS ETF Class A USD Accumulation's stock.
Sorry, we do not have any data on the number of employees for ARK Genomic Revolution UCITS ETF Class A USD Accumulation.
Sorry we do not have any infomation available on ARK Genomic Revolution UCITS ETF Class A USD Accumulation's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ARKG:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
